Business

Easton Pharmaceuticals Announces It Has Commenced Negotiations With An AMPR Applicant Towards a Marijuana Cultivators / Growers License For Canada; Provides iBliss Update

Easton Pharmaceuticals Announces It Has Commenced Negotiations With An AMPR Applicant Towards a Marijuana Cultivators / Growers License For Canada; Provides iBliss Update.

articleEaston Pharmaceuticals IncMarch 14, 20183/company/easton-pharmaceutica/news/easton-pharmaceuticals-announces-it-has-commenced-negotiations-with-an-ampr-applicant-towards-a-marijuana-cultivators-growers-license-for-canada-provides-ibliss-update
Easton Pharmaceuticals Announces It Has Commenced Negotiations With An AMPR Applicant Towards a Marijuana Cultivators / Growers License For Canada; Provides iBliss Update

About this update from Easton Pharmaceuticals Inc

[{"type":"text","content":"\n\n TORONTO, ON, March 14, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has commenced negotiations with an AMPR applicant towards a Canadian Marijuana cultivators / growers license. Provides iBliss update:\n Building on its medical marijuana business portfolio and following the agreement with Alliance Group (1124123 Ontario Limited), Easton Pharmaceuticals has initiated discussions with a new third party who has filed an application with Health Canada to receive an AMPR cultivators / growers license for the country of Canada. This opportunity brought forward by a board director, presents a company expecting to receive a compliance number from Health Canada in the near term. At that point Easton expects to sign a letter of intent or term sheet involving a transaction for Easton to possibly participate in the venture. This opportunity coincides with Alliance’s own medical / recreational marijuana initiative. So not to adversely affect Alliance’s marijuana venture, all details are being kept strictly confidential, but Alliance believes its initiatives are progressing well. Alliance will very soon be providing a detailed operations update on its aggregate business that Easton will be sharing with its shareholders. In other news, as previously disclosed, Easton and its partner BMV Medica SA de CV who have previously entered into an agreement with BAYER of Switzerland and the legal entity of their subsidiary company, BAYER Consumer Care for a sub distribution agreement for Easton / BMV’s licensed product known as VS-Sense for Mexico, is expected to soon provide an update that can be publicly shared. Easton / BMV entered into a sub-distribution Agreement which provided Easton an up-front cash payment with a second payment due at Product Launch. The agreement also included a royalty payment to Easton / BMV on each unit sold. Finally, Easton’s board has very recently had in depth meetings and discussions with iBliss Inc. and its principles towards modifying and closing on its agreement. The final closing with iBliss was delayed due to Easton having made the decision to first advance its available cash towards the Alliance closing. iBliss is a revenue generating e-liquid manufacturer and vaporizer company with international sales. Updates to be disclosed as they become availab...

More updates from Easton Pharmaceuticals Inc